PATHOLOGIC FINDINGS IN PREMENOPAUSAL PATIENTS WITH RECEPTOR-POSITIVE METASTATIC BREAST CANCER UNDERGOING BILATERAL SALPINGO-OOPHORECTOMY

被引：0
|
作者：
Wagner, M. [1 ]
Anton, C. [1 ]
Carvalho, J.
Testa, L. [1 ,2 ]
Ennes, A. [1 ]
Mayerhoff, E. [1 ]
机构：
[1] Inst Canc Estado Sao Paulo, Ginecol Obstetr, Sao Paulo, Brazil
[2] Inst Canc Estado Sao Paulo, Oncol Clin, Sao Paulo, Brazil
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2021年 / 31卷
关键词：
D O I：
10.1136/ijgc-2021-IGCS.90
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EPV023/#44
引用
收藏
页码：A38 / A39
页数：3
相关论文
共 50 条
  • [41] Laparoscopic bilateral salpingo-oophorectomy for recurrent ovarian endometriotic cysts in a woman taking adjuvant tamoxifen for breast cancer: A case report
    Takeuchi, Hajime
    Yagi, Koki
    Tokunaga, Naho
    Abe, Naoki
    Matsuno, Mariko
    Kira, Sachino
    Hayashi, Sotaro
    Lee, Lifa
    To, Yoko
    Nishiyama, Satoshi
    Goto, Maki
    Tsujioka, Hiroshi
    CASE REPORTS IN WOMENS HEALTH, 2024, 43
  • [42] Clinical background and outcomes of risk-reducing salpingo-oophorectomy for patients with hereditary breast and ovarian cancer in Japan
    Nomura, H.
    Sekine, M.
    Yokoyama, S.
    Takeshima, N.
    Arai, M.
    Nakamura, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [43] Comparison of outcomes in patients with luminal type breast cancer treated with a gonadotropin-releasing hormone analog or bilateral salpingo-oophorectomy: A cohort retrospective study
    Andriyanto, Dwi Ris
    Prihantono
    Syamsu, Salman Ardi
    Kusuma, Muhammad Ihwan
    Hendarto, Joko
    Indra
    Smaradania, Nilam
    Sampepajung, Elridho
    Mappiwali, Asrul
    Faruk, Muhammad
    ANNALS OF MEDICINE AND SURGERY, 2022, 77
  • [44] Sacituzumab Govitecan in Hormone Receptor-Positive Metastatic Breast Cancer
    Sg, Nithin
    Gogia, Ajay
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (08)
  • [45] Pathologic findings at risk-reducing salpingo-oophorectomy among women at increased ovarian cancer risk: Results from GOG-199.
    Mai, Phuong L.
    Sherman, Mark E.
    Piedmonte, Marion
    Ioffe, Olga B.
    Ronnett, Brigitte M.
    Van Le, Linda
    Mutch, David Gardner
    Cohn, David E.
    Thigpen, J. Tate
    Tewari, Krishnansu Sujata
    Disilvestro, Paul
    Kauff, Noah D.
    Lu, Karen H.
    Greene, Mark H.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] Fulvestrant in management of hormone receptor-positive metastatic breast cancer
    Shafaee, Maryam Nemati
    Ellis, Matthew James
    FUTURE ONCOLOGY, 2018, 14 (18) : 1789 - 1800
  • [47] Adjuvant Ovarian Function Suppression in Premenopausal Hormone Receptor-Positive Breast Cancer
    Basmadjian, Robert B.
    Lupichuk, Sasha
    Xu, Yuan
    Quan, May Lynn
    Cheung, Winson Y.
    Brenner, Darren R.
    JAMA NETWORK OPEN, 2024, 7 (03) : E242082
  • [48] OPTIMAL SYSTEMIC THERAPY FOR PREMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE BREAST CANCER
    Davidson, N.
    BREAST, 2013, 22 : S18 - S18
  • [49] Effects of fulvestrant in premenopausal women with oestrogen receptor-positive primary breast cancer
    Robertson, J.
    Semiglazov, V.
    Gee, J.
    Armstrong, J.
    EJC SUPPLEMENTS, 2004, 2 (03): : 73 - 74
  • [50] Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer
    Jankowitz, Rachel C.
    McGuire, Kandace P.
    Davidson, Nancy E.
    BREAST, 2013, 22 : S165 - S170
12345